Skip to content

Injectable cabotegravir makes progress towards human efficacy studies: doubts about injectable rilpivirine

Emerging epidemic of transmitted HIV drug resistance in low- and middle-income countries, with highest burden seen in MSM

Behavioural and financial incentives may improve HIV treatment outcomes

NNRTIs and protease inhibitors both good for first ART, channelling affects choices

No to treating our way out of the epidemic, say South African experts

Inflammatory markers associated with development of diabetes in people taking HIV therapy

Targeted adherence measures and viral load monitoring needed to improve retention in South African ART programme

Care programme improves clinic attendance and rates of virologic suppression among vulnerable HIV-positive patients in New York

HIV treatment roll-out has had only a modest impact on mortality in Lusaka, Zambia